| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 10.252 | 84.242 | 149.356 | 215.938 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 10.252 | 129.225 | 151.534 | 220.419 |
| Total Expenses - EUR | 232 | 0 | 0 | 0 | 0 | 0 | 5.890 | 89.603 | 179.611 | 245.209 |
| Gross Profit/Loss - EUR | -232 | 0 | 0 | 0 | 0 | 0 | 4.362 | 39.622 | -28.077 | -24.790 |
| Net Profit/Loss - EUR | -232 | 0 | 0 | 0 | 0 | 0 | 4.272 | 38.330 | -32.431 | -25.668 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 12 |
Check the financial reports for the company - Eurobiotech Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 369.326 | 1.207.183 | 1.468.719 | 1.420.909 |
| Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 191.028 | 215.383 | 73.558 | 75.857 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 292 | 3.347 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 186.615 | 186.287 | 56.821 | 43.166 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 4.414 | 29.096 | 16.445 | 29.344 |
| Shareholders Funds | -49.869 | -49.360 | -48.525 | -47.634 | -46.712 | -45.826 | 513.931 | 1.391.464 | 1.340.922 | 1.302.726 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 49.869 | 49.360 | 48.525 | 47.634 | 46.712 | 45.826 | 46.422 | 31.101 | 201.382 | 194.479 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4791 - 4791" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Eurobiotech Srl